📌 Key Takeaways
- Topic: Is Silicon Dioxide Toxic? Safety of Amorphous vs Crystalline Forms Explained
- Keywords: monocrystalline silicon
- Published: 2026-11-20 11:26:15
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Amorphous vs Crystalline Silica: Structure, Safety and Uses Compared
- Silica Testing Methods: How to Test Purity, Particle Size, BET and Moisture
- What Is Pyrogenic Silica? How It Is Made and Why It Is Used as a Thickener
- What Is Fused Silica Sand? Properties and Uses in Investment Casting and Refractories
- Silica Supplier Thailand: Market Overview and Sourcing Options
- 32. Voicu S.N.P., Dinu D., Sima C., Hermenean A., Ardelean A., Codrici E., Stan M.S., Zărnescu O., Dinischiotu A. Silica nanoparticles induce oxidative stress and autophagy but not apoptosis in the MRC-5 cell line. Int. J. Mol. Sci. 2015;16:29398-29416. doi: 10.3390/ijms161226171. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]
Silicon Dioxide Structure: Tetrahedral Network and Crystal Forms Explained
What is silica (SiO₂)?
Admatechs silica
What is the difference between fumed silica and precipitated silica?
hydrophilic fumed silica 107. Iveson S.M., Litster J.D., Hapgood K., Ennis B.J. Nucleation, growth and breakage phenomena in agitated wet granulation processes: A review. Powder Technol. 2001;117:3-39. doi: 10.1016/S0032-5910(01)00313-8. [ DOI ] [ Google Scholar ]
What drives silica raw material prices?
silica Mohs hardness Another study concentrated on repaglinide, an oral antidiabetic drug [ 84 ] from the BCS class II, with poor solubility but high permeability. In addition, it has a significant first-pass effect, and the combination of these two features results in low oral bioavailability. The researchers prepared a repaglinide solid dispersion employing mesoporous silica to enhance solubility and drug release. Based on in vitro tests, the repaglinide-MSN complex exhibited significant improvement, compared to the pure drug [ 84 ]. Then this solid dispersion was effectively incorporated into a medicated chewing gum. This buccal administration causes the drug to bypass first-pass metabolism, further boosting oral bioavailability. Based on their clinical investigations, the researchers proved that this formulation showed an increased antidiabetic activity compared to the marketed product by measuring blood glucose levels. In summary, this solid dispersion chewing gum formulation can be a promising perspective in antidiabetic therapy [ 84 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.